Overview of the clinical development of a diphtheria-tetanus-acellular pertussis vaccineBOGAERTS, H; CAPIAU, C; HAUSER, P et al.The Journal of infectious diseases. 1996, Vol 174, pp S276-S280, issn 0022-1899, SUP3Conference Paper

Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccines as a booster in 4-7-year-old children primed with diphtheria-tetanus-whole cell pertussis vaccine before 2 years of ageDAGAN, R; IGBARIA, K; PIGLANSKY, L et al.Vaccine. 1999, Vol 17, Num 20-21, pp 2620-2627, issn 0264-410XArticle